King & Spalding advises Gulf Investment Corporation

King & Spalding (in association with The Law Office of Mohammed Al-Ammar) advised Kuwait-based Gulf Investment Corporation in its acquisition of a minority stake in Sudair Pharmaceutical Company in Saudi Arabia. Sudair Pharma is developing SudairSpecialised Pharmaceutical Complex in the Sudair Industrial City for manufacturing of high-end generic drugs for cancer treatment.

The King & Spalding team on the matter was led by partner Simon Rahimzada and associate Melissa Chan as well as counsel Mohammad Al Ammar and associates Faris Al Louzi and Bader Al-Ammar.